Discontinued — last reported Q4 '24
Nordson Medical Fluid Systems — Operating profit (loss) remained flat by 0.0% to $46.93M in Q3 2024 compared to the prior quarter. Year-over-year, this metric declined by 0.9%, from $47.34M to $46.93M. Over 3 years (FY 2021 to FY 2024), Medical Fluid Systems — Operating profit (loss) shows relatively stable performance with a -1.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates improved margins, better cost control, or higher sales volume, while a decrease suggests operational challenges or margin compression.
This represents the profitability of the Medical Fluid Systems segment after deducting operating expenses, including cos...
A primary KPI for evaluating the performance of business segments in diversified industrial companies.
ndsn_segment_medical_fluid_systems_operating_profit_loss| FY'21 | FY'22 | FY'23 | FY'24 | |
|---|---|---|---|---|
| Value | $198.19M | $217.20M | $189.37M | $187.73M |
| YoY Change | — | +9.6% | -12.8% | -0.9% |